argenx SE (ARGX)
USD 535.04
(-3.62%)
USD 535.04
(-3.62%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.53 Billion USD | 38.89% |
| 2022 | 1.1 Billion USD | 30.14% |
| 2021 | 846.02 Million USD | 50.6% |
| 2020 | 561.76 Million EUR | 101.06% |
| 2019 | 279.4 Million EUR | 136.38% |
| 2018 | 118.2 Million EUR | 66.02% |
| 2017 | 71.19 Million EUR | 87.38% |
| 2016 | 37.99 Million EUR | 54.75% |
| 2015 | 24.55 Million EUR | 39.27% |
| 2014 | 17.63 Million EUR | 43.36% |
| 2013 | 12.29 Million EUR | -20.53% |
| 2012 | 15.47 Million EUR | 150.53% |
| 2011 | 6.17 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 936.29 Million USD | 108.32% |
| 2024 Q1 | 449.45 Million USD | 8.97% |
| 2023 Q2 | 347 Million USD | 14.04% |
| 2023 Q1 | 304.28 Million USD | 10.6% |
| 2023 FY | 1.52 Billion USD | 38.89% |
| 2023 Q3 | 373.63 Million USD | 7.68% |
| 2023 Q4 | 412.47 Million USD | 10.39% |
| 2022 Q3 | 336.35 Million USD | 37.44% |
| 2022 Q4 | 275.12 Million USD | -18.2% |
| 2022 Q1 | 244.76 Million USD | -8.7% |
| 2022 Q2 | 244.72 Million USD | -0.02% |
| 2022 FY | 1.1 Billion USD | 30.14% |
| 2021 Q4 | 268.08 Million USD | 25.38% |
| 2021 FY | 846.02 Million USD | 50.6% |
| 2021 Q1 | 169.32 Million EUR | 123.6% |
| 2021 Q2 | 217.1 Million USD | 28.22% |
| 2021 Q3 | 213.81 Million USD | -1.52% |
| 2020 Q4 | -717.39 Million USD | -1062.09% |
| 2020 FY | 561.76 Million EUR | 101.06% |
| 2020 Q3 | 74.56 Million EUR | 0.0% |
| 2019 Q2 | 63.7 Million EUR | 33.49% |
| 2019 Q4 | 93.81 Million EUR | 62.81% |
| 2019 FY | 279.4 Million EUR | 136.38% |
| 2019 Q1 | 47.72 Million EUR | 18.96% |
| 2019 Q3 | 57.62 Million EUR | -9.55% |
| 2018 FY | 118.2 Million EUR | 66.02% |
| 2018 Q2 | 25.75 Million EUR | 5.94% |
| 2018 Q4 | 40.11 Million EUR | 43.12% |
| 2018 Q3 | 28.02 Million EUR | 8.83% |
| 2018 Q1 | 24.3 Million EUR | 10.51% |
| 2017 FY | 71.19 Million EUR | 87.38% |
| 2017 Q4 | 21.99 Million EUR | 39.24% |
| 2017 Q3 | 15.79 Million EUR | -8.77% |
| 2017 Q2 | 17.31 Million EUR | 7.63% |
| 2017 Q1 | 16.08 Million EUR | 33.0% |
| 2016 Q1 | 5.88 Million EUR | -20.76% |
| 2016 FY | 37.99 Million EUR | 54.75% |
| 2016 Q4 | 12.09 Million EUR | 5.82% |
| 2016 Q3 | 11.43 Million EUR | 33.09% |
| 2016 Q2 | 8.58 Million EUR | 46.01% |
| 2015 Q1 | 4.8 Million EUR | -25.43% |
| 2015 FY | 24.55 Million EUR | 39.27% |
| 2015 Q4 | 7.42 Million EUR | 24.5% |
| 2015 Q3 | 5.96 Million EUR | -6.25% |
| 2015 Q2 | 6.35 Million EUR | 32.24% |
| 2014 Q2 | 4.04 Million EUR | 31.48% |
| 2014 FY | 17.63 Million EUR | 43.36% |
| 2014 Q4 | 6.44 Million EUR | 58.85% |
| 2014 Q3 | 4.05 Million EUR | 0.37% |
| 2014 Q1 | 3.07 Million EUR | 1.17% |
| 2013 Q3 | 1.77 Million EUR | -60.89% |
| 2013 Q2 | 4.53 Million EUR | 53.45% |
| 2013 Q1 | 2.95 Million EUR | 0.0% |
| 2013 FY | 12.29 Million EUR | -20.53% |
| 2013 Q4 | 3.04 Million EUR | 71.6% |
| 2012 FY | 15.47 Million EUR | 150.53% |
| 2011 FY | 6.17 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AbCellera Biologics Inc. | 275.23 Million USD | -457.177% |
| Alkermes plc | 996.24 Million USD | -53.931% |
| Agenus Inc. | 78.18 Million USD | -1861.462% |
| Aptorum Group Limited | 10.56 Thousand USD | -14513717.906% |
| Ardelyx, Inc. | 169.93 Million USD | -802.411% |
| Dyadic International, Inc. | 9.15 Million USD | -16654.954% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -6791.34% |
| Lantern Pharma Inc. | 17.87 Million USD | -8477.956% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -22679.898% |
| Novavax, Inc. | 779.12 Million USD | -96.827% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -1791.799% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -1765.699% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -7797.256% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -5079.795% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -2786.57% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -303.034% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -6209.107% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -3949.566% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -4883.686% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -1710.201% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -8684.614% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -810.453% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -4587.544% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -859.734% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | 14.807% |
| AlloVir, Inc. | 180.93 Million USD | -747.568% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -244.044% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -5066.532% |
| Bicycle Therapeutics plc | 216.92 Million USD | -606.95% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -792.095% |
| ChromaDex Corporation | 56.37 Million USD | -2620.038% |
| Chimerix, Inc. | 93.38 Million USD | -1542.088% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -10924.943% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -918.713% |
| CRISPR Therapeutics AG | 463.49 Million USD | -230.863% |
| Precision BioSciences, Inc. | 92.46 Million USD | -1558.534% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -503.647% |
| Fortress Biotech, Inc. | 200.19 Million USD | -666.018% |
| Fortress Biotech, Inc. | 200.19 Million USD | -666.018% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -4583.106% |
| ImmuCell Corporation | 9.61 Million USD | -15845.433% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -871.733% |
| Immix Biopharma, Inc. | 16.14 Million USD | -9400.77% |
| Incyte Corporation | 1.19 Billion USD | -28.814% |
| Innoviva, Inc. | 132.15 Million USD | -1060.411% |
| IO Biotech, Inc. | 91.44 Million USD | -1577.034% |
| Jaguar Health, Inc. | 42.01 Million USD | -3549.958% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -805.929% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -1718.638% |
| ContextLogic Inc. | 387 Million USD | -296.261% |
| MiMedx Group, Inc. | 229.72 Million USD | -567.545% |
| MEI Pharma, Inc. | 34.78 Million USD | -4308.596% |
| NextCure, Inc. | 67.63 Million USD | -2167.295% |
| Onconetix, Inc. | 34.9 Million USD | -4293.133% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -11931.461% |
| Opthea Limited | 191.96 Million USD | -698.849% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -55632.605% |
| Vaxcyte, Inc. | 468.04 Million USD | -227.649% |
| PDS Biotechnology Corporation | 43.04 Million USD | -3462.601% |
| Precigen, Inc. | 84.18 Million USD | -1721.706% |
| Pharming Group N.V. | 225.49 Million USD | -580.085% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -813.756% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -2013.29% |
| PureTech Health plc | 144.59 Million USD | -960.555% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -1077.257% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -525.527% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -6209.107% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -570.601% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -4869.474% |
| Acelyrin, Inc. | 422.06 Million USD | -263.341% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -11893261.253% |
| Summit Therapeutics Inc. | 87.68 Million USD | -1648.888% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -4037.519% |
| Senti Biosciences, Inc. | 94.7 Million USD | -1519.27% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -1141.192% |
| Elevation Oncology, Inc. | 45.44 Million USD | -3274.475% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -5103.875% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -38801.86% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -1060.227% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -4399.135% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -18046.137% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -745.848% |
| Seer, Inc. | 110.49 Million USD | -1287.936% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -2072.323% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -1540.525% |
| ESSA Pharma Inc. | 32.13 Million USD | -4672.282% |
| GlycoMimetics, Inc. | 39.28 Million USD | -3803.573% |
| GT Biopharma, Inc. | 13.57 Million USD | -11195.89% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -597.598% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -662.514% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -491.127% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -2601.827% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -2735.669% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -15331.523% |
| Sorrento Therapeutics, Inc. | 403.56 Million USD | -279.998% |
| TRACON Pharmaceuticals, Inc. | 18.92 Million USD | -8001.484% |
| Viracta Therapeutics, Inc. | 50.69 Million USD | -2925.132% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -490.594% |
| Aptose Biosciences Inc. | 52.35 Million USD | -2829.043% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -10541.847% |
| Soligenix, Inc. | 7.79 Million USD | -19572.619% |
| Century Therapeutics, Inc. | 56.07 Million USD | -2634.979% |
| Kura Oncology, Inc. | 165.8 Million USD | -824.905% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -1239.246% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -18334.067% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -61695.048% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -1323.917% |
| Autolus Therapeutics plc | 196.72 Million USD | -679.526% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -1711.463% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -1216.866% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -7811.727% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -376.61% |
| GRI Bio, Inc. | 11.33 Million USD | -13435.128% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -21634.623% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -1068.911% |
| IGM Biosciences, Inc. | 265.59 Million USD | -477.403% |
| INmune Bio, Inc. | 29.89 Million USD | -5029.549% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -788.725% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -3703.935% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -9496.942% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -9641.923% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -2369.532% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -1326.248% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -456.246% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -408.716% |
| Verastem, Inc. | 92.08 Million USD | -1565.36% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -8448.581% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -725.699% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -1163.131% |
| Histogen Inc. | 14.27 Million USD | -10645.025% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -9455.81% |
| Surrozen, Inc. | 18.55 Million USD | -8167.008% |
| Organovo Holdings, Inc. | 14.91 Million USD | -10181.797% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -30026.894% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -2469.882% |
| Panbela Therapeutics, Inc. | 25.64 Million USD | -5879.374% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -3162.413% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -19991.203% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -760.876% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -3065.314% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -525.92% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -9879.648% |
| Apollomics, Inc. | 54.14 Million USD | -2732.527% |
| Amarin Corporation plc | 272.35 Million USD | -463.059% |
| Mesoblast Limited | 5.9 Million USD | -25883.226% |
| Turnstone Biologics Corp. | 78.33 Million USD | -1857.581% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -528.182% |
| Synaptogenix, Inc. | 8.31 Million USD | -18345.477% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -10413.712% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -506.004% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -4501.04% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -17264.842% |
| Exelixis, Inc. | 1.58 Billion USD | 3.356% |
| Better Therapeutics, Inc. | 38.26 Million USD | -3907.971% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -560.862% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | -79.318% |
| NLS Pharmaceutics AG | 11.8 Million USD | -12888.243% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -18969.236% |
| Aridis Pharmaceuticals, Inc. | 29.99 Million USD | -5012.96% |
| Gritstone bio, Inc. | 148.37 Million USD | -933.557% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -2126.994% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -9273.53% |
| Avid Bioservices, Inc. | 25.99 Million USD | -5799.1% |
| Insmed Incorporated | 949.26 Million USD | -61.55% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -9674.065% |
| MediWound Ltd. | 18.86 Million USD | -8027.676% |
| OmniAb, Inc. | 83.89 Million USD | -1727.916% |
| Alector, Inc. | 248.8 Million USD | -516.366% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -554.493% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -2834.929% |
| Zai Lab Limited | 547.47 Million USD | -180.109% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -284.677% |
| Aura Biosciences, Inc. | 84.99 Million USD | -1704.344% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -520.516% |
| Immunic, Inc. | 99.22 Million USD | -1445.539% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -864.411% |
| Veracyte, Inc. | 357.93 Million USD | -328.441% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 82.991% |
| FibroGen, Inc. | 398.11 Million USD | -285.2% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -10691.907% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -22163.963% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -21421.017% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | 52.896% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -5827.144% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -384.462% |
| TG Therapeutics, Inc. | 198.47 Million USD | -672.657% |
| Galecto, Inc. | 35.62 Million USD | -4204.404% |
| Calithera Biosciences, Inc. | 40.68 Million USD | -3668.906% |
| Fortrea Holdings Inc. | 457.3 Million USD | -235.344% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -2725.325% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -5210.375% |
| XBiotech Inc. | 37.51 Million USD | -3988.323% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -2126.994% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -7326.655% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -979.487% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -1447.848% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -1285.102% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | -60.035% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -5216.45% |
| Vaxxinity, Inc. | 56.05 Million USD | -2635.955% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -256.105% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -6774.254% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -1283.216% |
| NexImmune, Inc. | 28.16 Million USD | -5344.322% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -27626.35% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -8470.793% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | 45.529% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -5923.528% |
| Scopus BioPharma Inc. | 11.71 Million USD | -12990.449% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -1106.915% |
| Ainos, Inc. | 12.95 Million USD | -11739.496% |
| Pluri Inc. | 22.48 Million USD | -6721.753% |
| Prothena Corporation plc | 282.4 Million USD | -443.023% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -666.681% |
| Celularity Inc. | 215.05 Million USD | -613.077% |
| Rallybio Corporation | 78.93 Million USD | -1842.85% |
| Cue Biopharma, Inc. | 19.54 Million USD | -7747.354% |
| MeiraGTx Holdings plc | 151.07 Million USD | -915.058% |
| Omeros Corporation | 94.75 Million USD | -1518.484% |
| Humacyte, Inc. | 23.49 Million USD | -6426.493% |
| Immunocore Holdings plc | 308.04 Million USD | -397.835% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -45136.873% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -1665.418% |
| Blueprint Medicines Corporation | 722.86 Million USD | -112.147% |
| CalciMedica, Inc. | 21.81 Million USD | -6929.06% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -1954.018% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -855.232% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -795.257% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -419.946% |
| Pulmatrix, Inc. | 22.03 Million USD | -6858.572% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -4335.372% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -1625.666% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | -178.032% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -2013.727% |
| Cytokinetics, Incorporated | 173.61 Million USD | -783.309% |
| Eloxx Pharmaceuticals, Inc. | 34.41 Million USD | -4355.475% |
| Nutriband Inc. | 5.73 Million USD | -26644.362% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -3416.222% |
| Vor Biopharma Inc. | 126.03 Million USD | -1116.74% |
| Roivant Sciences Ltd. | 1.18 Billion USD | -28.957% |
| Evogene Ltd. | 27.79 Million USD | -5418.28% |
| ProKidney Corp. | 151.52 Million USD | -912.084% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -1967.449% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -19836.06% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | -149.668% |
| CorMedix Inc. | 48.95 Million USD | -3032.351% |
| BioLineRx Ltd. | 50.8 Million USD | -2918.641% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -917.605% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -3927.973% |
| Atai Life Sciences N.V. | 125.78 Million USD | -1119.168% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -1778.421% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -1783.735% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -507.214% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -4583.965% |
| MediciNova, Inc. | 10.9 Million USD | -13968.741% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -1090.444% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -21024.388% |
| GeoVax Labs, Inc. | 6.02 Million USD | -25364.728% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | -221.927% |
| Biomea Fusion, Inc. | 126.13 Million USD | -1115.785% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | -16.899% |
| Mereo BioPharma Group plc | 35.84 Million USD | -4178.584% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -702.521% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -566.886% |
| Absci Corporation | 73.66 Million USD | -1981.734% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -5459.894% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -1047.938% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -533.266% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -485.21% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -637.295% |
| Allakos Inc. | 196.05 Million USD | -682.19% |
| Imunon, Inc. | 20.31 Million USD | -7450.457% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -1251.497% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -316.028% |
| BioAtla, Inc. | 129.68 Million USD | -1082.486% |
| NLS Pharmaceutics AG | 11.8 Million USD | -12888.243% |
| Bio-Path Holdings, Inc. | 15.84 Million USD | -9579.543% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -1705.895% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -3572.422% |
| XOMA Corporation | 46.46 Million USD | -3200.54% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -1279.433% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -976.441% |
| aTyr Pharma, Inc. | 12.97 Million USD | -11715.471% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -1379.442% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -787.1% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -501.941% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -3999.471% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -18545.163% |
| Akari Therapeutics, Plc | 16.8 Million USD | -9024.896% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -67338.445% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -412.341% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -22690.779% |
| UroGen Pharma Ltd. | 138.88 Million USD | -1004.149% |
| Sutro Biopharma, Inc. | 243 Million USD | -531.059% |
| ZIVO Bioscience, Inc. | 7.27 Million USD | -20980.545% |
| Orgenesis Inc. | 45.75 Million USD | -3251.465% |
| Entera Bio Ltd. | 8.86 Million USD | -17208.465% |
| GH Research PLC | 41.22 Million USD | -3620.174% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -5865.186% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -1746.447% |
| Xencor, Inc. | 306.97 Million USD | -399.559% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -30983.35% |
| Replimune Group, Inc. | 234.77 Million USD | -553.197% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -7384.326% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -699.563% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -22690.779% |
| Portage Biotech Inc. | 18.19 Million USD | -8326.452% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -21024.388% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -1361.047% |
| OncoCyte Corporation | 25.63 Million USD | -5881.706% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -25057.954% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -13285.021% |
| Purple Biotech Ltd. | -22.46 Million USD | 6925.7% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -9205.4% |
| scPharmaceuticals Inc. | 65.17 Million USD | -2252.834% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -18042.41% |
| HilleVax, Inc. | 133.34 Million USD | -1050.047% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -14810.355% |
| Tharimmune, Inc. | 9.45 Million USD | -16118.872% |
| Genprex, Inc. | 31.06 Million USD | -4837.225% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -717.769% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -4787.433% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -200361.438% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -28054.081% |
| OKYO Pharma Limited | 8243.57 USD | -18602641.288% |
| Savara Inc. | 15.74 Million USD | -9639.79% |
| Curis, Inc. | 58.35 Million USD | -2527.932% |
| Daré Bioscience, Inc. | 33.6 Million USD | -4462.801% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -30013.571% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -20453.947% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -5575.117% |
| BeiGene, Ltd. | 3.28 Billion USD | 53.34% |
| Kiromic BioPharma, Inc. | 19.93 Million USD | -7590.992% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | -207.465% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -898.054% |
| Erasca, Inc. | 141.52 Million USD | -983.575% |
| bluebird bio, Inc. | 240.23 Million USD | -538.354% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -33775.388% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | 12.183% |
| DBV Technologies S.A. | 92.16 Million USD | -1563.987% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -33775.388% |
| Moderna, Inc. | 6.39 Billion USD | 76.016% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -3499.075% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -10574.718% |
| Molecular Templates, Inc. | 63.09 Million USD | -2330.664% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -2199.111% |
| Travere Therapeutics, Inc. | 472 Million USD | -224.899% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -970.071% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -2370.168% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -3432.34% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -636.814% |
| MacroGenics, Inc. | 217.21 Million USD | -605.996% |
| RenovoRx, Inc. | 11.39 Million USD | -13356.739% |
| Adicet Bio, Inc. | 152.03 Million USD | -908.649% |
| Prime Medicine, Inc. | 186.63 Million USD | -721.656% |
| Aditxt, Inc. | 25.95 Million USD | -5809.383% |
| Adagene Inc. | 41.83 Million USD | -3565.982% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -20878.241% |
| Quantum-Si incorporated | 111.65 Million USD | -1273.405% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -792.365% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -10419.649% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -4180.973% |
| SciSparc Ltd. | 9.01 Million USD | -16918.422% |
| Vericel Corporation | 142.04 Million USD | -979.647% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -17615.023% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -6541.938% |
| Generation Bio Co. | 144.46 Million USD | -961.509% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -1746.959% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -1673.687% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -418.575% |
| Invivyd, Inc. | 205.75 Million USD | -645.318% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -2025.21% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -16251.542% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -1937.805% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -14807.456% |
| 2seventy bio, Inc. | 289.88 Million USD | -429.01% |
| ADMA Biologics, Inc. | 66.58 Million USD | -2203.082% |
| Clene Inc. | 41.07 Million USD | -3633.669% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -11873.326% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -2698.617% |
| GeoVax Labs, Inc. | 6.02 Million USD | -25364.728% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -335.603% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -4074.914% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -4446.756% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -1378.785% |
| Finch Therapeutics Group, Inc. | 32.58 Million USD | -4605.668% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -800.604% |
| Vir Biotechnology, Inc. | 767.72 Million USD | -99.751% |
| Evaxion Biotech A/S | 22.27 Million USD | -6786.08% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -1031.389% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -552.894% |
| Trevena, Inc. | 38.41 Million USD | -3892.216% |
| Surrozen, Inc. | 18.55 Million USD | -8167.008% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -1818.231% |
| Cingulate Inc. | 22.75 Million USD | -6638.07% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 20568.9% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -3333.25% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -18524.496% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -1395.281% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | -103.363% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -2370.487% |
| Clearmind Medicine Inc. | 8.74 Million USD | -17443.4% |
| Kronos Bio, Inc. | 128.11 Million USD | -1096.967% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -1724.067% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -52185.641% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -1420.952% |
| Statera Biopharma, Inc. | 28.82 Million USD | -5219.307% |
| ImmunityBio, Inc. | 362.87 Million USD | -322.609% |
| Korro Bio, Inc. | 84.53 Million USD | -1714.098% |
| Kineta, Inc. | 21.15 Million USD | -7148.676% |
| BioVie Inc. | 31.95 Million USD | -4699.75% |
| Codexis, Inc. | 66.51 Million USD | -2205.436% |
| Celularity Inc. | 215.05 Million USD | -613.077% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -576.694% |
| Celcuity Inc. | 66.23 Million USD | -2215.45% |
| Virax Biolabs Group Limited | 6.54 Million USD | -23323.175% |
| Cibus, Inc. | 320.3 Million USD | -378.772% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -3466.349% |
| eFFECTOR Therapeutics, Inc. | 33.84 Million USD | -4431.172% |
| IN8bio, Inc. | 30.33 Million USD | -4954.982% |
| Kodiak Sciences Inc. | 277.32 Million USD | -452.98% |
| Annexon, Inc. | 143.72 Million USD | -967.004% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -1101.911% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -6594.007% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -239514.063% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | -96.711% |
| Eyenovia, Inc. | 25.4 Million USD | -5935.988% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -992.92% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -27471.557% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -1837.915% |
| Arcellx, Inc. | 200.19 Million USD | -666.003% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -3241.024% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -608.619% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -15301.527% |
| Moolec Science SA | 52.75 Million USD | -2807.132% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -2408.309% |
| Geron Corporation | 70.44 Million USD | -2077.042% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -3195.08% |
| Royalty Pharma plc | 862.4 Million USD | -77.82% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -1530.166% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -16340.309% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -6676.975% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -637.941% |
| Humacyte, Inc. | 23.49 Million USD | -6426.493% |
| Structure Therapeutics Inc. | 102.77 Million USD | -1392.124% |
| 89bio, Inc. | 151.2 Million USD | -914.213% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -1813.755% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -10446.974% |
| Genelux Corporation | 24.33 Million USD | -6201.746% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -4420.62% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -787.105% |
| Notable Labs, Ltd. | 14.77 Million USD | -10282.735% |
| Liquidia Corporation | 87.98 Million USD | -1642.965% |
| Mustang Bio, Inc. | 48.5 Million USD | -3061.852% |
| Immunovant, Inc. | 282.7 Million USD | -442.441% |
| Quantum-Si incorporated | 111.65 Million USD | -1273.405% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -6702.386% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -7110.843% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -1403.284% |
| Acasti Pharma Inc. | 11.3 Million USD | -13469.861% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -6590.472% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -9496.942% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -3194.938% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -135062.792% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -9553.343% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -5159.56% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -3605.611% |
| PepGen Inc. | 84.76 Million USD | -1709.133% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -5075.424% |
| United Therapeutics Corporation | 885.1 Million USD | -73.261% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -6597.515% |
| Solid Biosciences Inc. | 104.31 Million USD | -1370.095% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -4586.035% |
| Immuneering Corporation | 58.41 Million USD | -2525.328% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -30026.894% |
| Silo Pharma, Inc. | 3.92 Million USD | -39002.15% |
| Belite Bio, Inc | 31.66 Million USD | -4742.522% |
| XOMA Corporation | 46.46 Million USD | -3200.54% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -2170.215% |
| Bionomics Limited | 17.89 Billion USD | 91.429% |
| Apogee Therapeutics, Inc. | 93 Million USD | -1548.904% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 4398.01% |
| uniQure N.V. | 285.08 Million USD | -437.918% |
| Cassava Sciences, Inc. | 105.95 Million USD | -1347.314% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -20878.241% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -689.637% |
| Forte Biosciences, Inc. | 32.47 Million USD | -4621.896% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -18356.796% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -5116.976% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -27471.557% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -10691.907% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -17151.997% |
| Altimmune, Inc. | 30.55 Million USD | -4918.752% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -258.594% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 4398.01% |
| Compugen Ltd. | 43.97 Million USD | -3387.594% |
| Peak Bio, Inc. | 1249.13 USD | -122767746.421% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -1968.983% |
| Benitec Biopharma Inc. | 22.38 Million USD | -6751.622% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -530.592% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -5272.701% |
| Zura Bio Limited | 62.63 Million USD | -2348.242% |
| PolyPid Ltd. | 21.04 Million USD | -7186.909% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -9322.032% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -5272.701% |
| Instil Bio, Inc. | 85.78 Million USD | -1687.644% |
| Immunome, Inc. | 122.82 Million USD | -1148.6% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -3063.679% |
| Verona Pharma plc | 67.15 Million USD | -2183.694% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -5824.396% |
| Shattuck Labs, Inc. | 93.61 Million USD | -1538.142% |
| CervoMed Inc. | 14.95 Million USD | -10152.399% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -2068.974% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -17848.619% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -2906.922% |
| Moolec Science SA | 52.75 Million USD | -2807.132% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -9223.255% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -1056.9% |
| AnaptysBio, Inc. | 181.56 Million USD | -744.604% |
| Design Therapeutics, Inc. | 78.19 Million USD | -1861.287% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -1661.848% |
| NeurAxis, Inc. | 8.82 Million USD | -17284.598% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -12085.379% |
| Lumos Pharma, Inc. | 38.66 Million USD | -3866.197% |
| Achilles Therapeutics plc | 75.25 Million USD | -1937.778% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -5824.396% |
| 180 Life Sciences Corp. | 13.47 Million USD | -11278.446% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -5686.372% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -52185.641% |
| Nutriband Inc. | 5.73 Million USD | -26644.362% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -1284.302% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -2655.521% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -2914.073% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -2220.05% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -2733.411% |
| Palisade Bio, Inc. | 13.32 Million USD | -11412.988% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -3277.15% |
| Beam Therapeutics Inc. | 554.19 Million USD | -176.714% |
| Neurogene Inc. | 55.58 Million USD | -2658.991% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -517.142% |
| AEON Biopharma, Inc. | 48.42 Million USD | -3066.553% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -1485.7% |
| Sesen Bio, Inc. | 78.38 Million USD | -1856.507% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -1735.925% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -12083.544% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -240.034% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -1644.829% |
| Athira Pharma, Inc. | 125.46 Million USD | -1122.267% |
| Vaccinex, Inc. | 23.45 Million USD | -6438.179% |
| HCW Biologics Inc. | 21.02 Million USD | -7192.967% |
| XOMA Corporation | 46.46 Million USD | -3200.54% |
| Nektar Therapeutics | 190.9 Million USD | -703.303% |
| Arvinas, Inc. | 480 Million USD | -219.485% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -67338.445% |
| Merus N.V. | 200.49 Million USD | -664.876% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -1383.75% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -4329.607% |
| Rezolute, Inc. | 70.38 Million USD | -2078.712% |
| Clene Inc. | 41.07 Million USD | -3633.669% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -9263.082% |
| BeyondSpring Inc. | 24.86 Million USD | -6067.424% |
| Synlogic, Inc. | 58.53 Million USD | -2519.986% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -8471.037% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -34039.136% |
| Peak Bio, Inc. | 1249.13 USD | -122767746.421% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -2437.025% |
| Krystal Biotech, Inc. | 160.42 Million USD | -855.911% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -466.65% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -340.621% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -71004.272% |
| MannKind Corporation | 125.59 Million USD | -1120.993% |
| Ikena Oncology, Inc. | 84.57 Million USD | -1713.176% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -15796.444% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -1611.51% |
| Gossamer Bio, Inc. | 183.75 Million USD | -734.533% |
| CohBar, Inc. | 12.38 Million USD | -12278.86% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -2923.283% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -5459.894% |
| Legend Biotech Corporation | 583.14 Million USD | -162.976% |
| Mural Oncology plc | 192.07 Million USD | -698.418% |
| Biora Therapeutics, Inc. | 67.14 Million USD | -2183.84% |
| PaxMedica, Inc. Common Stock | 16.14 Million USD | -9398.323% |
| Disc Medicine, Inc. | 91.12 Million USD | -1582.886% |
| Champions Oncology, Inc. | 28.11 Million USD | -5355.461% |
| REGENXBIO Inc. | 321.15 Million USD | -377.502% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -28504.049% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -2650.43% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -3836.1% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -1241.002% |
| Vaxart, Inc. | 90.72 Million USD | -1590.287% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -17899.162% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -3483.509% |
| Cellectis S.A. | 97.32 Million USD | -1475.76% |
| Longeveron Inc. | 21.25 Million USD | -7116.612% |
| Repare Therapeutics Inc. | 167.35 Million USD | -816.323% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | -12.692% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -1927.272% |
| Revolution Medicines, Inc. | 498.76 Million USD | -207.465% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -22953.668% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -3388.943% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -1955.946% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -2102.24% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -13765.552% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | 67.884% |
| Denali Therapeutics Inc. | 527.23 Million USD | -190.865% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -17615.023% |
| Veru Inc. | 101.34 Million USD | -1413.131% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -6451.587% |
| Cingulate Inc. | 22.75 Million USD | -6638.07% |
| Passage Bio, Inc. | 108.38 Million USD | -1314.839% |
| Context Therapeutics Inc. | 25.07 Million USD | -6016.354% |
| Exicure, Inc. | 14.07 Million USD | -10794.643% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -644.201% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -3441.558% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -16610.053% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -507.38% |
| Nuvalent, Inc. | 149.49 Million USD | -925.827% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -18910.148% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -1379.527% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -7049.657% |
| OmniAb, Inc. | 83.89 Million USD | -1727.916% |
| Anew Medical, Inc. | 1.3 Million USD | -117787.582% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -4580.534% |
| Lipocine Inc. | 15.08 Million USD | -10069.203% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -2138.305% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -1913.775% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -3703.935% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -1235.327% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -6751.01% |
| Sage Therapeutics, Inc. | 664.14 Million USD | -130.903% |
| Ocugen, Inc. | 71.56 Million USD | -2042.789% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -1533.744% |
| Q32 Bio Inc. | 92.68 Million USD | -1554.65% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -7142.514% |
| Alumis Inc. Common Stock | 158.17 Million USD | -869.521% |
| Equillium, Inc. | 50.6 Million USD | -2930.332% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -2357.344% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -10928.183% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -8028.922% |
| Galera Therapeutics, Inc. | 46.95 Million USD | -3166.235% |
| Evelo Biosciences, Inc. | 108.46 Million USD | -1313.835% |
| Comera Life Sciences Holdings, Inc. | 12.39 Million USD | -12274.435% |
| Dominari Holdings Inc. | 23.83 Million USD | -6333.942% |
| Edesa Biotech, Inc. | 9.22 Million USD | -16527.673% |
| vTv Therapeutics Inc. | 11.9 Million USD | -12779.231% |
| Bio-Techne Corporation | 563.03 Million USD | -172.367% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -275.124% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -470.603% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -1059.332% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -10541.385% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -836.816% |
| Nkarta, Inc. | 131.65 Million USD | -1064.854% |
| BioCardia, Inc. | 12.12 Million USD | -12551.844% |
| Iterum Therapeutics plc | 47.46 Million USD | -3130.661% |